During the past decade, Community Consortium of San Francisco conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Community Consortium of San Francisco" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Fujisawa Pharmaceutical Co" with 1 trials as a collaborator, "Glaxo Wellcome" with 1 trials as a collaborator and "Jacobus Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Community Consortium of San Francisco" are "HIV Infections" (15 trials), "Pneumonia, Pneumocystis Carinii" (2 trials), "Candidiasis" (1 trials), "Candidiasis, Esophageal" (1 trials) and "Cytomegalovirus Retinitis" (1 trials). Many other conditions were trialed in "Community Consortium of San Francisco" in a lesser frequency.

Most popular intervention types in "Community Consortium of San Francisco" are "Drug" (14 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Didanosine" (2 trials), "Indinavir sulfate" (2 trials), "Zalcitabine" (2 trials), "Amitriptyline hydrochloride" (1 trials) and "Amitriptyline hydrochloride placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Community Consortium of San Francisco" are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Community Consortium of San Francisco". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Community Consortium of San Francisco, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Community Consortium of San Francisco, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".